New Brunswick Scientific Co., Inc., Launches Miniature Innova(R) Direct-Heat Carbon Dioxide Incubator
29 Novembro 2005 - 9:00AM
PR Newswire (US)
EDISON, N.J., Nov. 29 /PRNewswire-FirstCall/ -- New Brunswick
Scientific Co., Inc. (NBS) (NASDAQ:NBSC), today announced the
roll-out of its Innova(R) CO-14 micro CO2 incubator, the latest in
NBS' line of CO2 Incubators, all featuring six-sided direct heat to
optimize temperature control while minimizing bench space, fanless
chamber convection and a large display with intuitive controls to
simplify operation. New Brunswick Scientific President and Chief
Operating Officer James Orcutt commented, "The Innova CO-14 is
ideally suited to in-vitro fertilization needs as well as any cell
culture work requiring isolation of sensitive samples. At less than
13 inches wide, the compact and efficient design of this 14
liter-capacity CO2 incubator enables single or stacked placement,
thereby occupying an exceptionally small footprint. "NBS' line of
state-of-the-art CO2 incubators, sold worldwide to life science and
biotech research customers in more than 40 countries, continues to
contribute meaningfully to consolidated revenues. Today's
announcement represents yet another in a series of new-product
launches during the current year resulting from our sustained
commitment to strategic investment in research and development,"
Orcutt concluded. To be added to New Brunswick Scientific's e-mail
distribution list, please click on the link below:
http://www.clearperspectivegroup.com/clearsite/nbsc/emailoptin.html
About New Brunswick Scientific New Brunswick Scientific Co., Inc.,
is a leading global provider of a comprehensive line of research
equipment and scientific instrumentation for use in the life
science industry. The Company's products are used in the creation,
maintenance and control of physical and biochemical environments
required for the growth, detection and storage of microorganisms
for medical, biological and chemical applications, as well as
environmental research and commercial product development. NBS is a
forerunner in the research and development of pioneering equipment
to meet the challenges of new areas of advancement in life science.
Established in 1946, New Brunswick Scientific is headquartered in
Edison, New Jersey, with sales and distribution facilities
strategically located in the United States, Europe and Asia. For
more information, please visit http://www.nbsc.com/ . This press
release contains "forward-looking statements" within the meaning of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements may be identified by words such as
"expects," "anticipates," "intends," "plans," "believes," "seeks,"
"estimates," "will" or words of similar meaning and include, but
are not limited to, statements about the expected future business
and financial performance of the Company. The forward-looking
statements involve a number of risks and uncertainties, including
but not limited to, changes in economic conditions, demand for the
Company's products, pricing pressures, intense competition in the
industries in which the Company operates, the need for the Company
to keep pace with technological developments and respond in a
timely manner to changes in customer needs, the Company's
dependence on third-party suppliers, the effect on foreign sales of
currency fluctuations, acceptance of new products, the labor
relations of the Company and its customers and other factors
identified in the Company's Securities and Exchange Commission
filings. Forward-looking statements are based on management's
current expectations and assumptions, which are inherently subject
to uncertainties, risks and changes in circumstances that are
difficult to predict. Actual outcomes and results may differ
materially from these expectations and assumptions due to changes
in global political, economic, business, competitive, market,
regulatory and other factors. The Company undertakes no obligation
to publicly update or review any forward-looking information,
whether as a result of new information, future developments or
otherwise. DATASOURCE: New Brunswick Scientific Co., Inc. CONTACT:
Samuel Eichenbaum, Vice President, Finance and Treasurer of New
Brunswick Scientific Co., Inc., +1-732-650-2500, ; or Matthew J.
Dennis, CFA, NBS Investor Relations, Clear Perspective Group, LLC,
+1-440-353-0552, Web site: http://www.nbsc.com/
Copyright
New Brunswick Scientific (NASDAQ:NBSC)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
New Brunswick Scientific (NASDAQ:NBSC)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024